Concepts (212)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Wound Healing | 10 | 2019 | 185 | 2.060 |
Why?
|
| Burns | 10 | 2018 | 100 | 1.540 |
Why?
|
| Wounds and Injuries | 6 | 2019 | 253 | 1.150 |
Why?
|
| Collagen | 4 | 2020 | 225 | 0.790 |
Why?
|
| Vitamin A Deficiency | 1 | 2019 | 4 | 0.700 |
Why?
|
| Vitamin A | 1 | 2019 | 21 | 0.690 |
Why?
|
| Vitamins | 1 | 2019 | 68 | 0.670 |
Why?
|
| Diabetic Foot | 2 | 2016 | 19 | 0.570 |
Why?
|
| Nutritional Support | 1 | 2016 | 4 | 0.560 |
Why?
|
| Pressure Ulcer | 1 | 2016 | 8 | 0.560 |
Why?
|
| Malnutrition | 1 | 2016 | 17 | 0.550 |
Why?
|
| Tympanic Membrane Perforation | 1 | 2016 | 1 | 0.540 |
Why?
|
| Explosive Agents | 1 | 2016 | 1 | 0.540 |
Why?
|
| Eye Foreign Bodies | 1 | 2016 | 2 | 0.540 |
Why?
|
| Finger Phalanges | 1 | 2016 | 7 | 0.540 |
Why?
|
| Multiple Trauma | 1 | 2016 | 41 | 0.520 |
Why?
|
| Blast Injuries | 1 | 2016 | 25 | 0.520 |
Why?
|
| Fractures, Bone | 1 | 2016 | 148 | 0.470 |
Why?
|
| Wound Infection | 3 | 2018 | 10 | 0.470 |
Why?
|
| Skin Transplantation | 4 | 2018 | 49 | 0.460 |
Why?
|
| Siloxanes | 1 | 2013 | 2 | 0.440 |
Why?
|
| Papilloma | 1 | 2013 | 9 | 0.440 |
Why?
|
| Morpholines | 1 | 2013 | 37 | 0.440 |
Why?
|
| Piperazines | 1 | 2013 | 54 | 0.430 |
Why?
|
| Dietary Supplements | 2 | 2019 | 185 | 0.430 |
Why?
|
| Skin Neoplasms | 2 | 2013 | 214 | 0.410 |
Why?
|
| Suction | 3 | 2006 | 10 | 0.390 |
Why?
|
| Chondroitin Sulfates | 2 | 2009 | 21 | 0.390 |
Why?
|
| Disease Models, Animal | 3 | 2013 | 1022 | 0.380 |
Why?
|
| Reconstructive Surgical Procedures | 3 | 2011 | 198 | 0.380 |
Why?
|
| Negative-Pressure Wound Therapy | 2 | 2011 | 35 | 0.380 |
Why?
|
| Soft Tissue Injuries | 2 | 2009 | 20 | 0.380 |
Why?
|
| Humans | 29 | 2020 | 32005 | 0.360 |
Why?
|
| Skin, Artificial | 4 | 2019 | 33 | 0.350 |
Why?
|
| Biocompatible Materials | 2 | 2019 | 232 | 0.350 |
Why?
|
| Skin | 3 | 2020 | 211 | 0.340 |
Why?
|
| Ambulatory Surgical Procedures | 1 | 2009 | 27 | 0.320 |
Why?
|
| Tryptophan | 1 | 2008 | 4 | 0.310 |
Why?
|
| Protein-Energy Malnutrition | 1 | 2008 | 4 | 0.310 |
Why?
|
| Food, Fortified | 1 | 2008 | 5 | 0.310 |
Why?
|
| Nutritional Requirements | 1 | 2008 | 16 | 0.300 |
Why?
|
| Adult | 16 | 2018 | 9345 | 0.300 |
Why?
|
| Electric Injuries | 1 | 2007 | 11 | 0.300 |
Why?
|
| Dietary Proteins | 1 | 2008 | 55 | 0.300 |
Why?
|
| Nerve Transfer | 1 | 2007 | 17 | 0.300 |
Why?
|
| Achilles Tendon | 1 | 2007 | 22 | 0.300 |
Why?
|
| Vacuum | 6 | 2008 | 22 | 0.280 |
Why?
|
| Surgical Wound Infection | 2 | 2011 | 84 | 0.280 |
Why?
|
| Breast Neoplasms | 1 | 2013 | 765 | 0.270 |
Why?
|
| Surgical Flaps | 2 | 2007 | 72 | 0.260 |
Why?
|
| Animals | 8 | 2020 | 7541 | 0.240 |
Why?
|
| Facial Injuries | 2 | 2016 | 12 | 0.230 |
Why?
|
| Lichen Planus | 1 | 2004 | 10 | 0.230 |
Why?
|
| Acitretin | 1 | 2004 | 18 | 0.230 |
Why?
|
| Clinical Trials as Topic | 1 | 2006 | 301 | 0.230 |
Why?
|
| Keratolytic Agents | 1 | 2004 | 29 | 0.230 |
Why?
|
| Carpal Tunnel Syndrome | 2 | 2015 | 62 | 0.210 |
Why?
|
| Atmospheric Pressure | 3 | 2009 | 10 | 0.210 |
Why?
|
| Male | 16 | 2020 | 19165 | 0.210 |
Why?
|
| Burn Units | 1 | 2002 | 27 | 0.210 |
Why?
|
| Pleural Diseases | 1 | 2002 | 1 | 0.200 |
Why?
|
| Respiratory Tract Fistula | 1 | 2002 | 2 | 0.200 |
Why?
|
| Bronchial Fistula | 1 | 2002 | 2 | 0.200 |
Why?
|
| Pneumonectomy | 1 | 2002 | 6 | 0.200 |
Why?
|
| Cutaneous Fistula | 1 | 2002 | 4 | 0.200 |
Why?
|
| Intensive Care Units | 1 | 2002 | 110 | 0.200 |
Why?
|
| Staphylococcal Infections | 2 | 2018 | 77 | 0.170 |
Why?
|
| Child | 5 | 2018 | 2438 | 0.170 |
Why?
|
| Administration, Oral | 1 | 2019 | 187 | 0.170 |
Why?
|
| Administration, Topical | 1 | 2019 | 140 | 0.170 |
Why?
|
| Water Microbiology | 1 | 2018 | 6 | 0.160 |
Why?
|
| Hydrotherapy | 1 | 2018 | 4 | 0.160 |
Why?
|
| Klebsiella Infections | 1 | 2018 | 6 | 0.160 |
Why?
|
| Equipment Contamination | 1 | 2018 | 12 | 0.160 |
Why?
|
| Middle Aged | 11 | 2018 | 11817 | 0.160 |
Why?
|
| Cross Infection | 1 | 2018 | 55 | 0.160 |
Why?
|
| Tissue and Organ Harvesting | 1 | 2018 | 35 | 0.160 |
Why?
|
| Edema | 2 | 2011 | 28 | 0.150 |
Why?
|
| Bandages | 3 | 2009 | 33 | 0.150 |
Why?
|
| Fibroblasts | 2 | 2020 | 111 | 0.150 |
Why?
|
| Female | 12 | 2018 | 19959 | 0.150 |
Why?
|
| Varicose Ulcer | 1 | 2016 | 2 | 0.140 |
Why?
|
| Tissue Engineering | 2 | 2020 | 656 | 0.140 |
Why?
|
| Occlusive Dressings | 2 | 2008 | 9 | 0.140 |
Why?
|
| Chronic Disease | 2 | 2016 | 406 | 0.140 |
Why?
|
| Lacerations | 1 | 2016 | 9 | 0.130 |
Why?
|
| Explosions | 1 | 2016 | 12 | 0.130 |
Why?
|
| Burns, Chemical | 1 | 2016 | 7 | 0.130 |
Why?
|
| Perioperative Care | 1 | 2016 | 59 | 0.130 |
Why?
|
| Compartment Syndromes | 2 | 2009 | 39 | 0.130 |
Why?
|
| Surgery, Plastic | 1 | 2016 | 27 | 0.130 |
Why?
|
| Eye Injuries | 1 | 2016 | 16 | 0.130 |
Why?
|
| Hand Injuries | 1 | 2016 | 23 | 0.130 |
Why?
|
| Arm Injuries | 1 | 2016 | 21 | 0.130 |
Why?
|
| Pressure | 3 | 2004 | 51 | 0.130 |
Why?
|
| Thoracic Injuries | 1 | 2016 | 50 | 0.130 |
Why?
|
| Ulnar Neuropathies | 1 | 2015 | 17 | 0.130 |
Why?
|
| Neuromuscular Junction | 1 | 2015 | 72 | 0.120 |
Why?
|
| Treatment Outcome | 5 | 2018 | 3306 | 0.120 |
Why?
|
| Adolescent | 5 | 2018 | 3539 | 0.120 |
Why?
|
| Drug Resistance, Bacterial | 2 | 2018 | 47 | 0.110 |
Why?
|
| 9,10-Dimethyl-1,2-benzanthracene | 1 | 2013 | 5 | 0.110 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 2013 | 11 | 0.110 |
Why?
|
| Mice, Inbred ICR | 1 | 2013 | 12 | 0.110 |
Why?
|
| Mice | 3 | 2020 | 2484 | 0.110 |
Why?
|
| Antigens, Viral | 1 | 2013 | 21 | 0.110 |
Why?
|
| Carcinogens | 1 | 2013 | 35 | 0.110 |
Why?
|
| Coculture Techniques | 1 | 2013 | 81 | 0.110 |
Why?
|
| Age Factors | 1 | 2016 | 1188 | 0.110 |
Why?
|
| Clinical Competence | 1 | 2016 | 333 | 0.110 |
Why?
|
| Child, Preschool | 3 | 2018 | 1269 | 0.110 |
Why?
|
| Stromal Cells | 1 | 2013 | 84 | 0.110 |
Why?
|
| Prospective Studies | 3 | 2018 | 2282 | 0.100 |
Why?
|
| Facial Transplantation | 1 | 2011 | 8 | 0.100 |
Why?
|
| Lung | 1 | 2013 | 249 | 0.100 |
Why?
|
| Steroids | 1 | 2011 | 38 | 0.100 |
Why?
|
| Abdominal Wall | 2 | 2008 | 22 | 0.090 |
Why?
|
| Median Nerve | 1 | 2011 | 51 | 0.090 |
Why?
|
| Cells, Cultured | 1 | 2013 | 833 | 0.090 |
Why?
|
| Regional Blood Flow | 1 | 2011 | 86 | 0.090 |
Why?
|
| Retrospective Studies | 5 | 2009 | 3509 | 0.090 |
Why?
|
| Public Policy | 1 | 2009 | 31 | 0.090 |
Why?
|
| Keloid | 1 | 2009 | 8 | 0.080 |
Why?
|
| Public Health | 1 | 2009 | 81 | 0.080 |
Why?
|
| External Fixators | 1 | 2007 | 15 | 0.070 |
Why?
|
| Diclofenac | 1 | 2007 | 3 | 0.070 |
Why?
|
| Amino Acids | 1 | 2008 | 46 | 0.070 |
Why?
|
| Debridement | 1 | 2007 | 43 | 0.070 |
Why?
|
| Sural Nerve | 1 | 2007 | 28 | 0.070 |
Why?
|
| Bacterial Infections | 1 | 2007 | 51 | 0.070 |
Why?
|
| Acute Disease | 2 | 2006 | 253 | 0.070 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2007 | 72 | 0.070 |
Why?
|
| Aged | 5 | 2018 | 10301 | 0.070 |
Why?
|
| Technology Assessment, Biomedical | 1 | 2006 | 11 | 0.070 |
Why?
|
| Science | 1 | 2006 | 8 | 0.070 |
Why?
|
| Equipment Design | 1 | 2006 | 171 | 0.060 |
Why?
|
| Smoke Inhalation Injury | 1 | 2005 | 6 | 0.060 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 2005 | 25 | 0.060 |
Why?
|
| Frostbite | 1 | 2004 | 1 | 0.060 |
Why?
|
| Nevus | 1 | 2004 | 15 | 0.060 |
Why?
|
| Surgical Wound Dehiscence | 1 | 2004 | 13 | 0.060 |
Why?
|
| Triamcinolone | 1 | 2004 | 11 | 0.060 |
Why?
|
| Staphylococcus aureus | 2 | 2018 | 53 | 0.060 |
Why?
|
| Scalp | 1 | 2004 | 38 | 0.060 |
Why?
|
| Clobetasol | 1 | 2004 | 26 | 0.060 |
Why?
|
| Mandibular Fractures | 1 | 2003 | 7 | 0.060 |
Why?
|
| Swine | 1 | 2004 | 215 | 0.060 |
Why?
|
| Fracture Fixation | 1 | 2003 | 35 | 0.060 |
Why?
|
| Costs and Cost Analysis | 1 | 2003 | 99 | 0.050 |
Why?
|
| Drug Therapy, Combination | 1 | 2004 | 288 | 0.050 |
Why?
|
| Surgical Mesh | 2 | 2018 | 48 | 0.050 |
Why?
|
| Rhabdomyolysis | 1 | 2002 | 6 | 0.050 |
Why?
|
| Myoglobin | 1 | 2002 | 11 | 0.050 |
Why?
|
| Patient Isolation | 1 | 2002 | 1 | 0.050 |
Why?
|
| Glucocorticoids | 1 | 2004 | 146 | 0.050 |
Why?
|
| Empyema, Pleural | 1 | 2002 | 7 | 0.050 |
Why?
|
| Pilot Projects | 2 | 2016 | 545 | 0.050 |
Why?
|
| Thoracic Surgical Procedures | 1 | 2002 | 13 | 0.050 |
Why?
|
| Young Adult | 2 | 2018 | 2636 | 0.050 |
Why?
|
| Mortality | 1 | 2002 | 125 | 0.050 |
Why?
|
| Ultrasonography | 2 | 2015 | 379 | 0.050 |
Why?
|
| Infant | 2 | 2018 | 1061 | 0.050 |
Why?
|
| Hospitalization | 1 | 2003 | 470 | 0.040 |
Why?
|
| Keratinocytes | 1 | 2020 | 29 | 0.040 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2020 | 98 | 0.040 |
Why?
|
| Zambia | 1 | 2018 | 1 | 0.040 |
Why?
|
| Disinfection | 1 | 2018 | 5 | 0.040 |
Why?
|
| Mice, Nude | 1 | 2020 | 291 | 0.040 |
Why?
|
| Hospitals, Teaching | 1 | 2018 | 31 | 0.040 |
Why?
|
| beta-Lactamases | 1 | 2018 | 13 | 0.040 |
Why?
|
| Klebsiella pneumoniae | 1 | 2018 | 14 | 0.040 |
Why?
|
| Hospitals, University | 1 | 2018 | 31 | 0.040 |
Why?
|
| Incidence | 1 | 2002 | 1199 | 0.040 |
Why?
|
| Transplantation, Autologous | 1 | 2018 | 80 | 0.040 |
Why?
|
| Muscle, Skeletal | 1 | 2002 | 519 | 0.040 |
Why?
|
| Extremities | 2 | 2009 | 50 | 0.040 |
Why?
|
| Aged, 80 and over | 2 | 2018 | 3990 | 0.040 |
Why?
|
| Regeneration | 1 | 2019 | 170 | 0.040 |
Why?
|
| Prevalence | 1 | 2018 | 981 | 0.030 |
Why?
|
| Electrodiagnosis | 1 | 2015 | 42 | 0.030 |
Why?
|
| Tissue Scaffolds | 1 | 2019 | 415 | 0.030 |
Why?
|
| Educational Measurement | 1 | 2016 | 123 | 0.030 |
Why?
|
| Erythrocyte Transfusion | 1 | 2011 | 35 | 0.020 |
Why?
|
| Transplantation, Homologous | 1 | 2011 | 151 | 0.020 |
Why?
|
| Neural Conduction | 1 | 2011 | 91 | 0.020 |
Why?
|
| Graft Rejection | 1 | 2011 | 238 | 0.020 |
Why?
|
| Public Health Practice | 1 | 2009 | 8 | 0.020 |
Why?
|
| Streptomycin | 1 | 2007 | 2 | 0.020 |
Why?
|
| Salmonella enterica | 1 | 2007 | 5 | 0.020 |
Why?
|
| Trifluoperazine | 1 | 2007 | 4 | 0.020 |
Why?
|
| Colony Count, Microbial | 1 | 2007 | 18 | 0.020 |
Why?
|
| DNA, Bacterial | 1 | 2007 | 27 | 0.020 |
Why?
|
| Plasmids | 1 | 2007 | 48 | 0.020 |
Why?
|
| Drug Synergism | 1 | 2007 | 66 | 0.020 |
Why?
|
| Culture Media | 1 | 2007 | 47 | 0.020 |
Why?
|
| Antipsychotic Agents | 1 | 2007 | 27 | 0.020 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2007 | 80 | 0.020 |
Why?
|
| Escherichia coli | 1 | 2007 | 87 | 0.020 |
Why?
|
| Escherichia coli Infections | 1 | 2007 | 39 | 0.020 |
Why?
|
| Mediastinitis | 1 | 2006 | 7 | 0.020 |
Why?
|
| Intestinal Fistula | 1 | 2006 | 9 | 0.020 |
Why?
|
| Perineum | 1 | 2006 | 18 | 0.020 |
Why?
|
| Sternum | 1 | 2006 | 14 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2011 | 2265 | 0.020 |
Why?
|
| Respiratory Function Tests | 1 | 2005 | 100 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2007 | 324 | 0.020 |
Why?
|
| Respiratory Insufficiency | 1 | 2005 | 57 | 0.010 |
Why?
|
| Intubation, Intratracheal | 1 | 2005 | 71 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2009 | 1426 | 0.010 |
Why?
|
| Hindlimb | 1 | 2002 | 54 | 0.010 |
Why?
|
| Rabbits | 1 | 2002 | 197 | 0.010 |
Why?
|
| Emergency Service, Hospital | 1 | 2003 | 474 | 0.010 |
Why?
|